Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
The Kv10.1 potassium channel, driver of hypoxia-induced EMT and breast cancer cell aggressiveness
by
Toillon, Robert-Alain
, Laîné, Mélanie
, Gutierrez, Laurent
, Jonckheere, Nicolas
, Gosselet, Fabien
, Girault, Alban
, Guénin, Stéphanie
, Ouadid-Ahidouch, Halima
, Mysiorek, Caroline
, Dehouck, Marie-Pierre
in
Biomedical and Life Sciences
/ Biomedicine
/ Breast cancer
/ Cancer Research
/ Cell Biology
/ EMT
/ HIF-1α
/ Hypoxia
/ Kv10.1
/ Life Sciences
/ Migration
2025
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The Kv10.1 potassium channel, driver of hypoxia-induced EMT and breast cancer cell aggressiveness
by
Toillon, Robert-Alain
, Laîné, Mélanie
, Gutierrez, Laurent
, Jonckheere, Nicolas
, Gosselet, Fabien
, Girault, Alban
, Guénin, Stéphanie
, Ouadid-Ahidouch, Halima
, Mysiorek, Caroline
, Dehouck, Marie-Pierre
in
Biomedical and Life Sciences
/ Biomedicine
/ Breast cancer
/ Cancer Research
/ Cell Biology
/ EMT
/ HIF-1α
/ Hypoxia
/ Kv10.1
/ Life Sciences
/ Migration
2025
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
The Kv10.1 potassium channel, driver of hypoxia-induced EMT and breast cancer cell aggressiveness
by
Toillon, Robert-Alain
, Laîné, Mélanie
, Gutierrez, Laurent
, Jonckheere, Nicolas
, Gosselet, Fabien
, Girault, Alban
, Guénin, Stéphanie
, Ouadid-Ahidouch, Halima
, Mysiorek, Caroline
, Dehouck, Marie-Pierre
in
Biomedical and Life Sciences
/ Biomedicine
/ Breast cancer
/ Cancer Research
/ Cell Biology
/ EMT
/ HIF-1α
/ Hypoxia
/ Kv10.1
/ Life Sciences
/ Migration
2025
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
The Kv10.1 potassium channel, driver of hypoxia-induced EMT and breast cancer cell aggressiveness
Journal Article
The Kv10.1 potassium channel, driver of hypoxia-induced EMT and breast cancer cell aggressiveness
2025
Request Book From Autostore
and Choose the Collection Method
Overview
Background
Kv10.1 potassium channel has been shown to be involved in breast cancer luminal cell proliferation and survival as well as migration in basal cell model in normoxia. Moreover, it is clearly established that solid tumors present a hypoxic center. Currently, few information is available about the involvement of the Kv10.1 channel in hypoxic context in breast cancer progression.
Methods
We explored the role of Kv10.1 in the hypoxia-induced aggressiveness promotion of different breast cancer cell models: luminal A (MCF-7 cells), HER2-overexpressing (SKBr3 cells) and basal subtype (MDA-MB-231 cells) by using complementary approaches of cell biology assay, western blot and qPCR.
Results
Our results show that Kv10.1 expression and function are related to hypoxia and HIF-1α. Under hypoxia, we demonstrated that Kv10.1 is a major actor of the migration and it regulates the hypoxia-induced EMT in the three cells models by promoting the mesenchymal phenotype. Finally, after RNAseq comparison of cells expressing or not the channel in hypoxia condition, we highlighted the involvement of the β1-integrin / FAK, AKT and ERK pathways in the MDA-MB-231 breast cancer cell aggressiveness.
Conclusion
We demonstrated, for the first time, the impact of Kv10.1 channel in hypoxia-induced aggressivity of breast cancer cells demonstrating its potential use as a complementary target to fight against metastasis development.
Publisher
BioMed Central,BMC
Subject
This website uses cookies to ensure you get the best experience on our website.